LINKYVET Linkyvet, telemedicine solution (teleconsultation by visio and/or chat) for...
LACLAREE Laclarée is a start-up company developing a novel eyewear solution for presbyopia...
OUBACCESS Digital Platform for Concierge Services and Shared...
SWIKLY Online down payments and security...
NUKEYGARA 3D animation software for video game and animated...
The Food and Drug Administration (FDA) issues a favorable opinion on the preclinical development plan submitted by Theranexus and BBDF
Presentation of the results of the phase IB Clinical study of THN201 for Alzheimer’s disease at the clinical trials on Alzheimer’s disease conference (CTAD)
Theranexus et BBDF obtain European “orphan medicinal product” designation for BBDF-101 in Batten disease
Amolyt Pharma Doses First Subject in Phase 1 Clinical Trial of Parathyroid Hormone Analog, AZP-3601, for Hypoparathyroidism
Theranexus presents its latest scientific news